Pioneering energy–based tools and products to the world since 1980

Inhalation Alzheimer's

Inhalation Alzheimer's

Alzheimer’s Disease (AD) is a neurodegenerative illness that in 2020 was diagnosed in 5.8 million Americans. Typically increasing with age, AD affects 1 in 9 people aged 65 and older. AD has long been associated with the accumulation of amyloid-beta proteins and intracellular tangles in the brain that lead to nerve death, cognitive decline and memory loss. However, research published in 2016 revealed that a subtype of Alzheimer’s disease, “type 3 (cortical)” is primarily the “result of exposure to specific toxins, and is most commonly inhalational (IAD), a phenotypic manifestation of chronic inflammatory response syndrome (CIRS), due to biotoxins such as mycotoxins.”[1]

Mycotoxins that can contribute to CIRS and IAD are produced by molds such as StachybotrysPenicillium, and Aspergillus that grow in water damaged homes and basements. Studies in 2014 and 2015 found fungal infections in the central nervous systems and brains of Alzheimer’s patients[2] thereby supporting a microbial aetiology for AD.[3]

Inhalation AD occurs typically in younger people (late 40s to early 60s) with symptom onset following a period of great stress. IAD is not amnestic (memory related) but is instead cortical with dyscalculia (learning disability in math) and/or aphasia (impairment of verbal or written language): “Imaging studies often indicate extra-hippocampal disease, with more general cerebral atrophy and frontal-temporal-parietal abnormalities…”[4]

Based on this research, promising treatments have been developed to help reverse IAD.[5] Dr. Dale Bredesen describes his approach and protocol in this 2020 TEDx Talk


Related Kits

Brain - Sarcodes

Mycotoxins – Common 75

Molds – Indoor

Mold & Yeast Pathogens





[4] Ibid


Previous post Next post